Sun Pharma shares up 3%; m-cap rises by ~3,260 cr

Shares of Sun Pharmaceutical Industries on Thursday rose by nearly 3 per cent, adding ~3,260 crore to its market valuation, after the company received establishment inspection report (EIR) from the US health regulator for its Dadra facility. The stock went up by 2.59 per cent to settle at ~539.40 on the BSE. During the day, it advanced by 4.22 per cent to ~548. At NSE, shares of the company climbed 2.56 per cent to close at ~539.55. The company's market valuation rose by ~3,260 crore to ~1,29,415 crore. PTI<